SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001626129-17-000186
Filing Date
2017-04-07
Accepted
2017-04-07 09:24:59
Documents
4
Effectiveness Date
2017-04-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS sndx-defa14a_051717.htm DEFA14A 26322
2 GRAPHIC sndx-defa14a_img001.jpg GRAPHIC 2896
3 GRAPHIC sndx-defa14a_img001.gif GRAPHIC 1505
4 GRAPHIC sndx-defa14a_img002.gif GRAPHIC 1512
  Complete submission text file 0001626129-17-000186.txt   35964
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37708 | Film No.: 17747874
SIC: 2834 Pharmaceutical Preparations